These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3053059)

  • 41. [Evaluation of complex therapy efficiency for urogenital tuberculosis].
    Iagafarova RK; Gamzakov RV; Manicheva OA
    Probl Tuberk; 1998; (2):38-40. PubMed ID: 9613186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?].
    Valencia ME; Moreno V; Laguna F; González-Lahoz JM
    Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):37-9. PubMed ID: 11256251
    [No Abstract]   [Full Text] [Related]  

  • 43. A new potent beta-lactamase inhibitor, BRL 42715, with inherent activity against Bacteroides fragilis group strains.
    Aldridge KE
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S335-8. PubMed ID: 8324143
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.
    Brown RB; Iannini P; Gross P; Kunkel M
    Chest; 2003 May; 123(5):1503-11. PubMed ID: 12740267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-lactam drugs and tuberculosis.
    Kernodle DS
    Clin Infect Dis; 1998 Apr; 26(4):878-9. PubMed ID: 9564468
    [No Abstract]   [Full Text] [Related]  

  • 46. HIV: prevention of opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2003 Dec; (10):809-30. PubMed ID: 15555123
    [No Abstract]   [Full Text] [Related]  

  • 47. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
    Zabner R; Quinn JP
    Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries.
    Dooley KE; Flexner C; Andrade AS
    J Infect Dis; 2008 Oct; 198(7):948-61. PubMed ID: 18713054
    [No Abstract]   [Full Text] [Related]  

  • 49. [The basic principles of rational chemotherapy in acute pneumonia].
    Martsinovskiĭ VIu; Sil'vestrov VP; Semin SN
    Ter Arkh; 1990; 62(3):22-9. PubMed ID: 2195692
    [No Abstract]   [Full Text] [Related]  

  • 50. [Community acquired pneumonia; no reason to revise current Dutch antibiotic guidelines].
    Oosterheert JJ; Bonten MJ; Schneider MM; Hoepelman IM
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):381-6. PubMed ID: 12661455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The beta-lactamase inhibitors: clinical pharmacology and rational application to combination antibiotic therapy.
    Abdel-Rahman SM; Kearns GL
    Pediatr Infect Dis J; 1998 Dec; 17(12):1185-94. PubMed ID: 9877381
    [No Abstract]   [Full Text] [Related]  

  • 52. [Role of beta-lactamase inhibitors in the etiotropic therapy of infectious diseases].
    Orlov VA; Sarsenbaeva DI
    Antibiot Khimioter; 1993; 38(4-5):63-70. PubMed ID: 8031200
    [No Abstract]   [Full Text] [Related]  

  • 53. [Combined preparations of semisynthetic penicillins and beta-lactamase inhibitors: a method for overcoming resistance and the broadening of therapeutic possibilities].
    Antibiot Khimioter; 2000; 45(3):3. PubMed ID: 10768056
    [No Abstract]   [Full Text] [Related]  

  • 54. Hospital-acquired respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Akova M
    Int J Clin Pract Suppl; 2002 Mar; (125):19-27; discussion 37-9. PubMed ID: 12014853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.
    Tiberi S; D'Ambrosio L; De Lorenzo S; Viggiani P; Centis R; Sotgiu G; Alffenaar JW; Migliori GB
    Eur Respir J; 2016 Jan; 47(1):333-6. PubMed ID: 26585427
    [No Abstract]   [Full Text] [Related]  

  • 56. Aminoglycosides versus beta-lactams in gram-negative pneumonia.
    Collins T; Gerding DN
    Semin Respir Infect; 1991 Sep; 6(3):136-46. PubMed ID: 1754734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Penicillins and beta-lactamase inhibitors].
    Gac Med Mex; 1992; 128(2):127-30. PubMed ID: 1302208
    [No Abstract]   [Full Text] [Related]  

  • 58. Treating diarrhoea.
    Gorbach SL
    BMJ; 1997 Jun; 314(7097):1776-7. PubMed ID: 9224070
    [No Abstract]   [Full Text] [Related]  

  • 59. Update on antimicrobial agents.
    Walsh ML; Johnson CC
    Nurs Clin North Am; 1991 Jun; 26(2):341-60. PubMed ID: 2047288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.